COVID-19 and Cardiovascular Diseases: From Cellular Mechanisms to Clinical Manifestations

Hongyang Shu1,2, Zheng Wen1,2, Na Li1,2

  • 1Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.

Aging and Disease
|May 18, 2023
PubMed

Insights

Coronavirus disease 2019 (COVID-19) significantly impacts cardiovascular health, increasing risks for patients with pre-existing conditions and causing new cardiac issues post-infection and vaccination.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Virology

Background:

  • COVID-19, caused by SARS-CoV-2, has led to a global health crisis with significant mortality.
  • The virus primarily infects cells via the ACE2 receptor, which is also present in cardiac tissue.
  • A strong association between COVID-19 and cardiovascular disease (CVD) is increasingly evident.

Purpose of the Study:

  • To review the multifaceted impact of COVID-19 on cardiovascular health.
  • To elucidate the mechanisms underlying COVID-19's cardiovascular complications.
  • To discuss cardiovascular risks post-recovery and those associated with vaccination.

Main Methods:

  • Review of existing clinical evidence and scientific literature.
  • Analysis of the effects of SARS-CoV-2 on various myocardial cell types.
  • Overview of clinical manifestations of cardiovascular involvement during the pandemic.

Main Results:

  • COVID-19 exacerbates pre-existing cardiovascular conditions and can lead to new cardiac issues like myocardial damage, heart failure, and thromboembolism.
  • The virus affects cardiomyocytes, pericytes, endothelial cells, and fibroblasts within the heart.
  • Increased cardiovascular risks are observed both after COVID-19 recovery and following vaccination.

Conclusions:

  • COVID-19 poses a significant threat to cardiovascular health through direct viral effects and exacerbation of underlying conditions.
  • Understanding the cardiovascular impact is crucial for managing patients during and after the pandemic.
  • Further research is needed on long-term cardiovascular consequences and vaccine-related cardiac events.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
24
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
17
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
16
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
376
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
57
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
34